New obesity pill enters early human testing in china
NCT ID NCT07499050
First seen Apr 02, 2026 · Last updated Apr 29, 2026 · Updated 3 times
Summary
This early-stage study tests an experimental oral drug, RO7795081, in 30 healthy Chinese adults who are overweight or have obesity. The main goal is to check the drug's safety and how the body processes it, not yet to prove weight loss. Participants are randomly assigned to receive either the drug or a placebo, and neither they nor the researchers know who gets which.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanjing Gulou Hospital
RECRUITINGNanjing, DUMMY_VALUE, China
-
Ruijin Hospital Shanghai Jiaotong University School of Medicine
RECRUITINGShanghai, 200003, China
Conditions
Explore the condition pages connected to this study.